US FDA approves Sanofi's drug for a rare blood disorder

Swedish Orphan Biovitrum AB (publ)

29/08/2025 22:53

Aug 29 (Reuters) - The U.S. Food and Drug Administration has approved Sanofi's SASY.PA drug to treat a type of blood disorder, the company said on Friday, in a sign that the French drugmaker's $3.7 billion bet on the treatment could start to pay off.

 (Reporting by Bhanvi Satija, Puyaan Singh and Sriparna Roy in Bengaluru; Editing by Shilpi Majumdar)

 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))